ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BRADLEY HARRIS M.D.

Internal Medicine

8,784

$542K

669
593 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

GREGG OSTERGREN DO

Internal Medicine

17,522

$1.14M

661
595 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $56

ALAIN LAMBERT MD

Internal Medicine

9,099

$471K

658
589 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

DONALD LEE MD

Internal Medicine

10,881

$679K

657
477 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

KENNETH SHIBATA MD

Internal Medicine

11,660

$573K

652
487 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

MANDEEP SAINI MD

Internal Medicine

9,492

$549K

649
523 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $56

HOWARD LICHTENSTEIN M.D.

Internal Medicine

11,430

$541K

647
533 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

SANJIT DUTTA MD

Internal Medicine

13,429

$614K

645
527 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

FRANCIS AMADO MERCADO M.D.

Internal Medicine

12,462

$790K

640
541 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $56

JOHN MITCHELL MD

Internal Medicine

11,641

$539K

637
522 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

JOSEPH PALERMO DO

Internal Medicine

19,377

$966K

635
542 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

LAIRD FINDLAY MD

Internal Medicine

9,674

$465K

634
561 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

HENRY RETAILLIAU MD

Internal Medicine

10,865

$578K

633
543 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $56

BRYAN JOHNSON M.D.

Internal Medicine

21,611

$1.04M

629
519 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

DANIEL HIGHKIN MD

Internal Medicine

11,407

$498K

625
549 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

DAVID YOUNG MD

Internal Medicine

10,025

$514K

622
558 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

CYRIL DODGE MD

Internal Medicine

13,007

$669K

620
567 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $56

DANIEL WACHENHEIM MD

Internal Medicine

7,698

$340K

619
518 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

BICH-KHANH NGUYEN M.D.

Internal Medicine

9,454

$533K

617
564 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

ANA MIHALCEA MD

Internal Medicine

8,105

$346K

615
558 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

PETER BOSAK MD

Internal Medicine

10,502

$644K

615
519 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$61
Average prescription price

Avg: $56

ALEX NAJERA MD

Internal Medicine

21,723

$1.27M

613
456 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

32%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

DONALD SHARMAN MD

Internal Medicine

12,980

$806K

608
473 are 65+

16%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $56

PATRICK LYNCH MD

Internal Medicine

11,903

$470K

605
507 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $56

CARL WEBER M.D.

Internal Medicine

7,482

$469K

599
528 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$63
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank